Mavromanoli, Anna C.
Barco, Stefano
Ageno, Walter
Bouvaist, Hélène
Brodmann, Marianne
Cuccia, Claudio
Couturaud, Francis
Dellas, Claudia
Dimopoulos, Konstantinos
Duerschmied, Daniel
Empen, Klaus
Faggiano, Pompilio
Ferrari, Emile
Galiè, Nazzareno
Galvani, Marcello
Ghuysen, Alexandre
Giannakoulas, George
Huisman, Menno V.
Jiménez, David
Kozak, Matija
Lang, Irene M.
Meneveau, Nicolas
Münzel, Thomas
Palazzini, Massimiliano
Petris, Antoniu Octavian
Piovaccari, Giancarlo
Salvi, Aldo
Schellong, Sebastian
Schmidt, Kai-Helge
Verschuren, Franck
Schmidtmann, Irene
Toenges, Gerrit
Klok, Frederikus A.
Konstantinides, Stavros V. http://orcid.org/0000-0001-6359-7279
Freire, Jaime Antonio Abelaira
Akin, Ibrahim
Anusic, Toni
Becker, Dorothea
Bertoletti, Laurent
Bettoni, Giuseppe
Binder, Harald
Carels, Regina
Di Pasquale, Giuseppe
Dürschmied, Daniel
Enea, Iolanda
Ficker, Joachim
Genth-Zotz, Sabine
Girard, Philippe
Gorbulev, Stanislav
Held, Matthias
Hobohm, Lukas
Huisman, Menno V
Konstantinides, Stavros V
Kronfeld, Kai
Lang, Irene Marthe
Lankeit, Mareike
Lehmacher, Walter
Miguel, Concepcion Patricia Lopez
Martin, Nadine
Meyer, Guy
Pareznik, Roman
Quitzau, Kurt
Parepa, Irinel Raluca
Martin, Purificacion Ramirez
Righini, Marc
Todea, Silviu Bogdan
Torbicki, Adam
Valerio, Luca
Vanassche, Thomas
Vida-Simiti, Luminita Animarie
Wolf-Pütz, Anamaria
,
Funding for this research was provided by:
The PEITHO-2 trial was funded by the German Federal Ministry of Education and Research, University Medical Center Mainz, and Boehringer Ingelheim.
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 18 September 2022
Accepted: 1 December 2022
First Online: 21 December 2022
Declarations
:
: SB reports grants or contracts from Bayer, INARI, Boston Scientific, Medtronic, Bard, SANOFI, and Concept Medical; consulting fees from INARI; payment or honoraria from INARI, Boston Scientific, and Concept Medical; and support for attending meetings and/or travel from Bayer and Daiichi Sankyo. WA reports grants or contracts from Bayer; payment or honoraria from Bayer, Daiichi Sankyo, Pfizer-BMS, Werfen, Aspen, and Leo Pharma; and participation on a Data Safety Monitoring Board or Advisory Board for Bayer, BMS-Pfizer, Sanofi, Viatris, Norgine, and Leo Pharma. FC reports grants or contracts from Bayer and BMS Pfizer; consulting fees from Bayer, BMS, Pfizer, and Astra; and support for attending meetings and/or travel from Bayer, BMS/Pfizer, Leo Pharma, and Actelion. KD reports unrestricted research support and speaker/consultant fees from Janssen. DD reports consulting fees from Boston Scientific; payment or honoraria from Bayer Healthcare, Daiichi Sankyo, BMS/Pfizer, and Leo Pharma; support for attending meetings and/or travel from Bayer Healthcare, Daiichi Sankyo, and BMS/Pfizer; and participation on a Data Safety Monitoring Board or Advisory Board for Bayer Healthcare and Daiichi Sankyo. KE reports consulting fees from Bayer Vital. GG reports consulting fees, payment or honoraria from Bayer, Boehringer Ingelheim, Leo, and Pfizer. MVH reports grants from ZonMW Dutch Healthcare Fund, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer Health Care, Aspen, and Daiichi-Sankyo. DJ reports grants or contracts from Daiichi Sankyo, Sanofi, and ROVI; and consulting fees, payment or honoraria from Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Leo Pharma, Pfizer, ROVI, and Sanofi. MK reports payment or honoraria from Pfizer, Boehringer Ingelheim, and Bayer AG. IML reports grants or contracts and consulting fees from Janssen and AOPHealth; payment or honoraria from MSD, Ferrer, Janssen, and AOPHealth; and support for attending meetings and/or travel from Novomed. NM reports grants or contracts from BMS/Pfizer, Bayer Healthcare, Medtronic, and Abbott; consulting fees from INARI, Boston Scientific, Terumo, and Abbott; payment or honoraria and support for attending meetings and/or travel from BMS-Pfizer, Bayer Healthcare, and Abbott; and participation on a Data Safety Monitoring Board or Advisory Board for INARI, Boston Scientific, Terumo, and Abbott. AOP reports payment or honoraria from AlfaSigma Romania SRL, Terapia SA Romania, Servier Pharma SRL, Pfizer Romania SRL, Boehringer Ingelheim, SC Bayer SRL, Egis Pharmaceuticals RLC, Novartis Pharma Services Romania SRL, S > C > Berlin-Chemie Menarini SRL, Zentiva SRL, and Sanofi Romania RL. SS reports consulting fees and speaker fees from Aspen and Boehringer Ingelheim, speaker fees from Bayer AG and Daiichi-Sankyo, and project funding and speaker fees from Pfizer/Bristol-Myers Squibb. FV reports research grants from Daiichi-Sanyo, Boehringer Ingelheim, Radiometer, and Biomerieux. IS reports stock or stock options from Dräger. FAK reports grants or contracts from Bayer, BMS, Boehringer Ingelheim, MSD, Daiichi Sankyo, and Actelion. SVK reports grants or contracts from Bayer AG; consulting fees from Bayer AG, Daiichi Sankyo, and Boston Scientific; and payment or honoraria from Bayer AG, Boston Scientific, MSD, Pfizer, and Bristol-Myers Squibb. All other authors (ACM, HB, MB, CC, CD, PF, EF, NG, MG, AG, TM, MP, GP, AS, K-HS, GT) declare no competing interests.